Carumonam
![]() | |
Systematic (IUPAC) name | |
---|---|
2-[[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-(carbamoyloxymethyl)-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxyacetic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number |
87638-04-8 ![]() |
ATC code | J01DF02 (WHO) |
PubChem | CID 6857983 |
ChemSpider |
5257278 ![]() |
UNII |
486890PI06 ![]() |
ChEMBL |
CHEMBL1256767 ![]() |
Chemical data | |
Formula | C12H14N6O10S2 |
Molar mass | 466.40 g/mol |
| |
| |
![]() ![]() |
Carumonam (INN) is a monobactam antibiotic.[1]
References
- ↑ McNulty, C. A.; Garden, G. M.; Ashby, J.; Wise, R. (1985). "Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam". Antimicrobial Agents and Chemotherapy 28 (3): 425–427. doi:10.1128/aac.28.3.425. PMC 180266. PMID 4073864.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.